Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
JAML mediates monocyte and CD8 T cell migration across the brain endothelium.
Validation of an Arabic version of Fatigue Severity Scale.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
Lung volume recruitment in multiple sclerosis.
AQP4 autoantibody assay performance in clinical laboratory service.
TRANSGLUTAMINASE 2 IS INVOLVED IN HOMOCYSTEINE-INDUCED ACTIVATION OF HUMAN THP-1 MONOCYTES.
Diagnosis and quantification of cognitive fatigue in multiple sclerosis.
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
Teriflunomide - a new oral agent for multiple sclerosis treatment.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.
Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high throughput amplicon sequencing.
Jean-Martin Charcot, father of modern neurology: an homage 120 years after his death.
A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysis.
Waldenstrom's Macroglobulinaemia Presenting as Demyelinating Polyradiculoneuropathy.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Multiple sclerosis in malaysia: demographics, clinical features, and neuroimaging characteristics.
Pages
« first
‹ previous
…
544
545
546
547
548
549
550
551
552
…
next ›
last »